[HTML][HTML] Insights into manganese superoxide dismutase and human diseases

M Liu, X Sun, B Chen, R Dai, Z Xi, H Xu - International Journal of …, 2022 - mdpi.com
Redox equilibria and the modulation of redox signalling play crucial roles in physiological
processes. Overproduction of reactive oxygen species (ROS) disrupts the body's antioxidant …

[HTML][HTML] Biological and clinical implications of comorbidities in Parkinson's disease

JA Santiago, V Bottero, JA Potashkin - Frontiers in aging …, 2017 - frontiersin.org
A wide spectrum of comorbidities has been associated with Parkinson's disease (PD), a
progressive neurodegenerative disease that affects more than seven million people …

[HTML][HTML] Parkinson's disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis

G DeMaagd, A Philip - Pharmacy and therapeutics, 2015 - ncbi.nlm.nih.gov
Parkinson’s Disease and Its Management - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …

Analysis of the relationship between type II diabetes mellitus and Parkinson's disease: a systematic review

F Camargo Maluf, D Feder… - Parkinson's …, 2019 - Wiley Online Library
In the early sixties, a discussion started regarding the association between Parkinson's
disease (PD) and type II diabetes mellitus (T2DM). Today, this potential relationship is still a …

Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease

JA Santiago, JA Potashkin - Proceedings of the National …, 2015 - National Acad Sciences
Environmental and genetic factors are likely to be involved in the pathogenesis of
Parkinson's disease (PD), the second most prevalent neurodegenerative disease among the …

[HTML][HTML] Development of halogenated-chalcones bearing with dimethoxy phenyl head as monoamine oxidase-B inhibitors

NA Rehuman, JM Oh, MA Abdelgawad, EAM Beshr… - Pharmaceuticals, 2022 - mdpi.com
Two series of dimethoxy-halogenated chalcones (DM1–DM20) were synthesized and tested
for their ability to inhibit monoamine oxidase (MAOs). Compound DM2 exhibited the most …

[HTML][HTML] Dissecting the molecular mechanisms of neurodegenerative diseases through network biology

JA Santiago, V Bottero, JA Potashkin - Frontiers in aging …, 2017 - frontiersin.org
Neurodegenerative diseases are rarely caused by a mutation in a single gene but rather
influenced by a combination of genetic, epigenetic and environmental factors. Emerging …

[HTML][HTML] Parkinson's disease between internal medicine and neurology

I Csoti, WH Jost, H Reichmann - Journal of Neural Transmission, 2016 - Springer
General medical problems and complications have a major impact on the quality of life in all
stages of Parkinson's disease. To introduce an effective treatment, a comprehensive …

A network approach to clinical intervention in neurodegenerative diseases

JA Santiago, JA Potashkin - Trends in molecular medicine, 2014 - cell.com
Network biology has become a powerful tool to dissect the molecular mechanisms triggering
neurodegeneration. Recent developments in network biology have led to the discovery of …

[HTML][HTML] hsa-miR-518-5p/hsa-miR-3135b regulates the REL/SOD2 pathway in ischemic cerebral infarction

B Zhao, X Jiang - Frontiers in Neurology, 2022 - frontiersin.org
Objectives Ischemic cerebral infarction (ICI) is a fatal neurovascular disorder. A
bioinformatics approach based on single-cell and bulk RNA-seq analyses was applied to …